Expanding the Phenotypic and Functional Evidence for KCNK3 as a Neurodevelopmental Disorder Gene: A New Chinese Case and Drosophila Validation.

Clin GenetJul 24, 2026 (epub)
Case ReportMedical GeneticsNeurologyOpen access

Yuanyuan Sun, Leyi Wang, Liwei Zhang et al.

✦ AI-curated · Sources linked

Case in brief

A 2-year-old girl presented with generalized hypotonia and delayed language development, leading to the identification of a de novo missense variant in the KCNK3 gene through trio-whole exome sequencing. This case expands the understanding of KCNK3's role in neurodevelopmental disorders, supported by Drosophila model studies that demonstrated its function as a dosage-sensitive regulator of neurodevelopment.

Diagnostic / clinical pearl

Clinicians should consider KCNK3 as a potential candidate gene in cases of neurodevelopmental disorders, particularly when presented with developmental delays and hypotonia.

Why it matters

This case highlights the importance of reanalyzing genetic data and utilizing model organisms to uncover the roles of genes previously associated with other conditions, thereby broadening the understanding of neurodevelopmental disorders.

Source

Published in Clin Genet. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Medical Genetics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.